Le Lézard
Classified in: Health, Business, Covid-19 virus
Subject: LIC

WellsCare signs in-store contract with b8ta for IASO


SEOUL, South Korea, Sept. 20, 2020 /PRNewswire/ -- WellsCare, a member company of the Born2Global Centre, recently signed a store contract with b8ta, a famous American flagship store that is dedicated to innovative products. WellsCare has been an active member of the Born2Global Centre since 2019.

Based on the contract, WellsCare will be selling IASO, its hands-free wearable cold laser pain relief device, at all 18 b8ta locations in the United States. Starting in October with the New York, San Francisco, Texas, and Seattle stores, IASO will be made available sequentially in stores throughout the country.

IASO is the global brand of Epione, a wearable smart LoT laser therapy device developed independently by WellsCare.

IASO is capable of treating not only VDT (visual display terminals syndrome), a group of disorders that includes carpal tunnel and turtle neck (straight neck) syndromes, that are caused by the excessive use of smartphones and personal computers, but also providing at-home treatment for sports injuries (tennis elbow, golfer's elbow, etc.) and chronic diseases. Its defining characteristic is its use of cold laser technology, which is used by orthopedic and rehabilitative hospitals for pain treatment, rather than low-frequency massage/LED technologies.

WellsCare CEO Lee Sung-won said, "B8ta's decision to sell IASO in its stores proves both our product's innovativeness and the fact that it is highly marketable and has significant growth potential in the United States, the world's largest market for medical devices. We hope to broaden our international sales channels, both online and offline, by cementing IASO's unrivaled status in the home healthcare device market, which is gaining increasing recognition due to COVID-19."

WellsCare was also recently granted a Class III medical device permit by the Korean government. The outcomes of clinical tests of IASO conducted at large Korean hospitals will soon be published in a US-based academic journal on clinical testing.

For more detailed information on WellsCare, visit https://www.wellscare.net/.

About WellsCare
WellsCare (www.wellscare.net) was founded in 2016 by a team of highly proficient and experienced engineers who aimed to introduce innovation in the field of pain management. Headquartered in Seoul, South Korea, WellsCare aims to lead the smart health device market with its advanced technology and innovation.

About Born2Global Centre

Born2Global Centre (www.born2global.com) is a full-cycle service platform for global expansion. Since inception in 2013, Born2Global has been setting the standard for successful startup ecosystem as the main Korean government agency under the Ministry of Science and ICT. Born2Global has expanded and transformed startups to be engaged, equipped and be connected with the global market.

Media contact

WellsCare: hjsuh@wellscare.kr  
Born2Global Centre: jlee@born2global.com

SOURCE Born2Global Centre


These press releases may also interest you

at 11:59
Unifor members working at Fiat Chrysler in Brampton, Etobicoke, Windsor, Mississauga, Montreal and Red Deer have voted ­78 per cent to ratify a new three year collective agreement that includes significant investment, job security and economic gains....

at 11:58
Thrivent Advisor Network, the platform for independent purpose-driven advisors looking to deliver financial advice as part of a community with shared values, has hired RIA industry veteran Matthew Sines as Senior Business Development Officer. Sines...

at 11:43
California's home-buying season extended further into September as home sales climbed to their highest level in more than a decade, and the median home price set another high for the fourth straight month, the CALIFORNIA ASSOCIATION OF REALTORS®...

at 11:38
Mitchell Smith, President, CEO & Director, Global Energy Metals Corp. , shares his company's story in an interview with TMX Group.   The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto...

at 11:35
The Think Global Awards are delighted to announce four additional judges for the awards program, running for the fourth consecutive year. Lahcene Guerrouj, Salesforce Alex Katsambas, Farfetch Puneet K. Bhargava, Deloitte Sinéad Mac Aodha, Literature...

at 11:33
BioMatrix Specialty Pharmacy announced today preferred network status with AscellaHealth for both intravenous and subcutaneous immunoglobulin (IG) therapy treating patients in the neurology, immunology, transplant, and rare disease space. The...



News published on 20 september 2020 at 08:00 and distributed by: